Pharmaceuticals News

The pharmaceuticals news email from Wiser has been specifically designed for anyone with an interest in the industry. This includes medical practitioners, investors and those involved in research and development. By its very nature, the pharmaceutical industry is subject to constant change. It is a research-driven industry with companies spending much of their revenues developing new medicines and vaccines. As a result patients are able to get new and more effective treatments. This is helping to increase the life expectancy of individuals in most countries. But there are challenges. The costs of the research and development can be large which puts up the price of drugs, while governments and the medical industry argue to try to keep prices as low as possible. The industry also faces challenges from alternatives, both legal (through generic drugs) and illegal (through black market economies). To follow the latest developments in this industry you should sign up for the pharmaceuticals news email from Wiser. It is the best way to find must-read articles on the topic from around the web.

Recent Pharmaceuticals News Coverage
 
Your Weekly Recommendations Sunday, February 18, 2018
 
Recommended for you
Reporters highlight the budget bill’s impact on older adults
Covering Health • Liz Seegert
Stada Looks East in Expansion Push
Bloomberg • Misha Savic
Coverage: Roche is buying Flatiron Health for $1.9 billion
Talking Biz News • Chris Roush
Bio Roundup: Trump’s Budget, Biogen’s AD Reveal, Hugin’s Run & More
Xconomy • Alex Lash
In An Effort To Curb Drug Costs, States Advance Bills To Prod Feds On Importation
Kaiser Health News • Kaiser Health News, Shefali Luthra
Big data to help online pharmacies stay in shape
The Economic Times of India • J. Vignesh
Cytokinetics' (CYTK) CEO Robert Blum on Q4 2017 Results - Earnings Call Transcript
Seeking Alpha
Roche to Acquire Cancer Software Startup Flatiron Health for $1.9B
Xconomy • Frank Vinluan
Drug maker hikes price of 2-in-1 painkiller >2,000%—$36 drugs now $3,000
Ars Technica • Beth Mole
FDA Head Vows To Tackle High Drug Prices And Drugmakers ‘Gaming The System’
Kaiser Health News • Kaiser Health News, Liz Szabo, Sarah Jane Tribble
 
Recommended for You
AARP, Affordable Care Act
Reporters highlight the budget bill’s impact on older adults
Covering HealthLiz Seegert
Liz Seegert (@lseegert), is AHCJ’s topic editor on aging. Her work has appeared in NextAvenue.com, Journal of Active Aging, Cancer Today, Kaiser Health News, the Connecticut Health I-Team and other outlets. She is a senior fellow at the Center for Health Policy...
Share
GlaxoSmithKline plc, Pharmaceuticals
Stada Looks East in Expansion Push
BloombergMisha Savic
Targets to include smaller drug makers with niche products Stada to add more inhouse production to improve efficiency Stada Arzneimittel AG will shop around for niche drug producers in central and eastern Europe to fuel expansion plans and boost regional sales growth...
Share
Business Reporting, Cancer
Coverage: Roche is buying Flatiron Health for $1.9 billion
Talking Biz NewsChris Roush
Swiss pharmaceutical giant Roche Group is buying Flatiron Health, an Alphabet-backed cancer-focused startup founded by two former Google employees, for $1.9 billion. Christina Farr of CNBC.com had the news: Flatiron was valued at $1.2 billion when it raised its last round from...
Share
Cancer, GlaxoSmithKline plc
Bio Roundup: Trump’s Budget, Biogen’s AD Reveal, Hugin’s Run & More
XconomyAlex Lash
National — Another week of White House chaos and American gun violence. Amid it all, we tried to parse what the Trump administration’s 2019 budget proposal meant for the biomedical and life-science worlds. There was talk of tackling high drug prices in...
Share
GlaxoSmithKline plc, Health Care Costs
In An Effort To Curb Drug Costs, States Advance Bills To Prod Feds On Importation
Kaiser Health NewsKaiser Health News, Shefali Luthra
Norm Thurston is a “free-market guy” — a conservative health economist in Republican-run Utah who rarely sees the government’s involvement in anything as beneficial. But in a twist, the state lawmaker is now pushing for Utah to flex its muscle to spur...
Share
Health Insurance, Health Insurance Policy
Big data to help online pharmacies stay in shape
The Economic Times of IndiaJ. Vignesh
BENGALURU: Epharmacy 1mg Technologies’ chief executive Prashant Tandon has set up a small team of data scientists whose only job is to tinker around with available data and come up with interesting models with a potential to be turned into products in...
Share
Health Finance, Pharmaceuticals
Cytokinetics' (CYTK) CEO Robert Blum on Q4 2017 Results - Earnings Call Transcript
Seeking Alpha
Cytokinetics (NASDAQ:CYTK) Q4 2017 Earnings Conference Call February 15, 2018 4:30 AM ET Executives Diane Weiser - IR Robert Blum - President and CEO Fady Malik - EVP of Research & Development Andy Wolff - SVP & Chief Medical Officer Peter Roddy...
Share
Cancer, Electronic Health Records
Roche to Acquire Cancer Software Startup Flatiron Health for $1.9B
XconomyFrank Vinluan
New York — Roche has agreed to acquire Flatiron Health for $1.9 billion, a deal that brings the cancer research capabilities of Flatiron to the oncology drug portfolio and pipeline of the pharmaceutical giant. Roche already owns a 12.6 percent stake in...
Share
Economic Policy, Finance
Drug maker hikes price of 2-in-1 painkiller >2,000%—$36 drugs now $3,000
Ars TechnicaBeth Mole
Irish drug company Horizon Pharma has hiked the price of a two-in-one painkiller by more than 2,000 percent in the past five years, according to a report in Financial Times A 60-pill bottle of the drug combo, Vimovo, cost $138 in 2013...
Share
Cancer, Health Reform
FDA Head Vows To Tackle High Drug Prices And Drugmakers ‘Gaming The System’
Kaiser Health NewsKaiser Health News, Liz Szabo, Sarah Jane Tribble
Food and Drug Administration Commissioner Scott Gottlieb said he will do everything “within my lane” to combat high drug prices and that he sees drug companies “gaming the system to try to block competition” in a multitude of ways in the marketplace....
Share